Drug factory · FDA FEI 1000390117
Chifeng Pharmaceutical Co. Ltd
#1, Chiyao Road, Chifeng Hongshan new and high-tech industrial development zone, Hongshan District, Chifeng, China
Problems found, fixed voluntarily at FDA's last inspection, Jan 19, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2012: 1 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Griseofulvin | Makes the active ingredient | Cipla USA., Inc. | 69097-361 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jan 19, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Oct 13, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 3, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Oct 16, 2013 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Aug 2, 2012 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.